Trump Administration Hands Out Record Number of Orphan Drug Approvals

A federal incentive for research into rare diseases for so-called orphan drugs is beloved by pharmaceutical companies. And during Donald Trump’s first two years in office, the Food and Drug Administration has been authorizing them at an unprecedented rate, according to Axios. Rare diseases are those that affect 200,000 or fewer people in the country, […]

Drug Companies Have Big R&D Expenses and Still Make Large Profits

Pharmaceutical companies have come under harsh criticism over how much they charge, whether hiking prices on long-existing drugs, trying executive pay to drug prices, or making critical medicines difficult to afford by those who depend on them. Drugmakers historically have blamed higher prices on the costs of research and development. And it is true that […]

Senator Calls Tying Drugmaker CEO Pay to High Drug Price ‘Problematic’

AbbVie CEO Richard Gonzalez found himself getting grilled by a Senate panel on Tuesday about executive compensation and the price of the blockbuster drug Humira. You’ve likely heard of it, as stumbling across television commercials for Humira is easy. Pharmaceutical manufacturer AbbVie, a 2013 spin-off from Abbott Laboratories keeps them running on a regular basis, […]